Home · Open Lab · Lot RGX-26-SS-668
RGX-26-SS-668Superseded
SS-31 (Elamipretide) · 10 MG · Obesity Research · COA NS-2026-05140

Release test results

99.742%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.05 mg
Related impurities (total)0.258%
Endotoxin<1.0 EU/mg
HPLC retention time7.8 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundSS-31 (Elamipretide)
Presentation10 MG
Lot numberRGX-26-SS-668
COA numberNS-2026-05140
Test date24 Jan 2026
Release date27 Jan 2026
Independent labNordicstar Labs
StatusSuperseded

SS-31 (Elamipretide) — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-SS-103210 MGJul 23, 202699.731%Current
RGX-26-SS-103350 MGJul 22, 202699.555%Current
RGX-26-SS-76810 MGApr 8, 202699.746%Superseded
RGX-26-SS-76750 MGApr 4, 202699.704%Superseded
RGX-26-SS-668 this lot10 MGJan 24, 202699.742%Superseded
RGX-26-SS-66750 MGJan 5, 202699.666%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →